Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma-Reference-Cited by-同舟云学术

Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma

Published:2005-01 Issue:2 Volume:128 Page:177-183
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Korfel Agnieszka,Martus Peter,Nowrousian Mohammad R.,Hossfeld Dieter K.,Kirchen Heinz,Brucher Joachim,Stelljes Matthias,Birkmann Josef,Peschel Christian,Pasold Rita,Fischer Lars,Jahnke Kristoph,Thiel Eckhard,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2004.05284.x/fullpdf

Reference23 articles.

1. Long-term survival in primary CNS lymphoma.

2. Treatment for Primary CNS Lymphoma: The Next Step

3. Selection bias in clinical trials.

4. Guidelines for Reporting Clinical Trials

5. The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression [see comments]

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in the management of primary central nervous system lymphoma;Critical Reviews in Oncology/Hematology;2023-08

2. Diagnostik und Therapie des primären ZNS-Lymphoms;InFo Hämatologie + Onkologie;2021-07

3. Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome;Cancers;2021-06-11

4. High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials;Scientific Reports;2021-01-22

5. Primary CNS Lymphoma;Oncology of CNS Tumors;2019